Working with the pharmaceutical and life sciences sector

British Heart Foundation (BHF) may partner with companies in the pharmaceutical and life sciences sector where doing so clearly benefits people affected by heart and circulatory diseases. Any support we receive does not influence our independent decision‑making, policy positions, campaigning, research funding or the information we provide.

We publish details of any financial or in‑kind support from this sector - including the company name, amount or value and purpose - on this page and in our annual report.

We also require our partners to publish their support to BHF on their own websites in line with the ABPI Code of Practice.

BHF does not promote prescription‑only medicines to the public. Any information we provide to the public is balanced, factual and non‑promotional and complies with MHRA guidance (Blue Guide).

BHF does not endorse specific products, medicines or companies; and partnerships will not be used to promote or imply endorsement of particular treatments.